| |
| |
|
| Insider
Information: |
Sing George L |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
26,349 |
|
|
Indirect Shares
|
2,150 |
|
|
| Direct
Value |
$23,271,437 |
|
|
|
Indirect Value
|
$1,898,880 |
|
|
| Total
Shares |
28,499 |
|
|
| Total
Value |
$25,170,317 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
34
|
|
Stock
price went up :
|
0
|
14
|
| Stock
price went down : |
0
|
20
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -43.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-02-26 |
26,349 |
2024-02-26 |
2,150 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-26 |
4 |
OE |
$413.33 |
$413,330 |
D/D |
1,000 |
26,849 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-26 |
4 |
S |
$990.00 |
$992,500 |
D/D |
(1,000) |
26,349 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-23 |
4 |
S |
$985.00 |
$492,500 |
D/D |
(500) |
26,349 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-23 |
4 |
OE |
$413.33 |
$206,665 |
D/D |
500 |
26,849 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-22 |
4 |
OE |
$413.33 |
$1,239,990 |
D/D |
3,000 |
27,349 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-22 |
4 |
S |
$960.00 |
$2,895,000 |
D/D |
(3,000) |
26,349 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-09 |
4 |
OE |
$413.33 |
$206,665 |
D/D |
500 |
26,849 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-09 |
4 |
S |
$955.00 |
$477,500 |
D/D |
(500) |
26,349 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-08 |
4 |
S |
$945.00 |
$472,500 |
D/D |
(500) |
26,349 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-08 |
4 |
OE |
$413.33 |
$206,665 |
D/D |
500 |
26,849 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
135 |
26,349 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
165 |
26,214 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-02-28 |
4 |
S |
$614.00 |
$1,231,000 |
D/D |
(2,000) |
26,049 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-02-25 |
4 |
S |
$621.00 |
$1,242,000 |
D/D |
(2,000) |
28,049 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
191 |
30,049 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-11-18 |
4 |
S |
$650.00 |
$2,600,000 |
D/D |
(4,000) |
32,858 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-11-16 |
4 |
S |
$650.00 |
$487,500 |
I/I |
(750) |
1,000 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-11-16 |
4 |
S |
$650.00 |
$3,937,580 |
D/D |
(6,000) |
36,858 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-30 |
4 |
S |
$670.00 |
$369,100 |
I/I |
(550) |
1,750 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-30 |
4 |
S |
$670.00 |
$672,500 |
D/D |
(1,000) |
42,858 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-26 |
4 |
S |
$672.00 |
$100,800 |
I/I |
(150) |
1,000 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-16 |
4 |
S |
$627.50 |
$627,500 |
I/I |
(1,000) |
2,050 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-16 |
4 |
S |
$630.00 |
$444,150 |
D/D |
(705) |
43,858 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-13 |
4 |
S |
$620.00 |
$310,000 |
D/D |
(500) |
44,563 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-12 |
4 |
S |
$611.00 |
$611,000 |
D/D |
(1,000) |
45,063 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
